Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network.

http://www.ncbi.nlm.nih.gov/pubmed/22657748

AIMS: The study evaluated the effectiveness of an 8-week combined group plus individual 12-step facilitative intervention on stimulant drug use and 12-step meeting attendance and service. DESIGN: Multisite randomized controlled trial, with assessments at baseline, mid-treatment, end of treatment, and 3- and 6-month post-randomization follow-ups (FUs). SETTING: Intensive outpatient substance treatment programs. PARTICIPANTS: Individuals with stimulant use disorders (n = 471) randomly assigned to treatment as usual (TAU) or TAU into which the Stimulant Abuser Groups to Engage in 12-Step (STAGE-12) intervention was integrated. MEASUREMENTS: Urinalysis and self-reports of substance use and 12-step attendance and activities. INTERVENTION: Group sessions focused on increasing acceptance of 12-step principles; individual sessions incorporated an intensive referral procedure connecting participants to 12-step volunteers. FINDINGS: Compared with TAU, STAGE-12 participants had significantly greater odds of self-reported stimulant abstinence during the active 8-week treatment phase; however, among those who had not achieved abstinence during this period, STAGE-12 participants had more days of use. STAGE-12 participants had lower Addiction Severity Index Drug Composite scores at and a significant reduction from baseline to the 3-month FU, attended 12-step meetings on a greater number of days during the early phase of active treatment, engaged in more other types of 12-step activities throughout the active treatment phase and the entire FU period, and had more days of self-reported service at meetings from mid-treatment through the 6-month FU. CONCLUSIONS: The present findings are mixed with respect to the impact of integrating the STAGE-12 intervention into intensive outpatient drug treatment compared with TAU on stimulant drug use. However, the results more clearly indicate that individuals in STAGE-12 had higher rates of 12-step meeting attendance and were engaged in more related activities throughout both the active treatment phase and the entire 6-month FU period than did those in TAU.

Pubmed ID: 22657748 RIS Download

Mesh terms: Adult | Central Nervous System Stimulants | Female | Follow-Up Studies | Humans | Male | Middle Aged | National Institute on Drug Abuse (U.S.) | Patient Compliance | Recurrence | Referral and Consultation | Self-Help Groups | Severity of Illness Index | Substance Abuse Detection | Substance-Related Disorders | Time Factors | Treatment Outcome | United States

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIDA NIH HHS, Id: U10 DA013714
  • Agency: NIDA NIH HHS, Id: U10 DA020024
  • Agency: NIDA NIH HHS, Id: U10DA13036
  • Agency: NIDA NIH HHS, Id: U10DA13045
  • Agency: NIDA NIH HHS, Id: U10DA13714
  • Agency: NIDA NIH HHS, Id: U10DA13720
  • Agency: NIDA NIH HHS, Id: U10DA13727
  • Agency: NIDA NIH HHS, Id: U10DA13732
  • Agency: NIDA NIH HHS, Id: U10DA20024
  • Agency: NIDA NIH HHS, Id: U10DA20036
  • Agency: NIDA NIH HHS, Id: UG1 DA020024

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.